Grail's Slump Enters Week: Navigating Biotech's Setback
Grail's stock has slid as its Galleri MCED test faced a major trial setback. This piece breaks down what happened, wh...
We compare expense ratios across dividend growth ETFs to identify the lowest-cost options for long-term investing.
28,176 articlesGrail's stock has slid as its Galleri MCED test faced a major trial setback. This piece breaks down what happened, wh...
A fresh AI-driven marketing platform launches a Reg A+ offering at $0.85 per share, claiming strong ROI through AI-po...
Two affordable biotech names are drawing attention for potential low-beta growth as AI-driven tools reshape pipelines...
Realtor.com rolls out a refreshed portal strategy focused on MLS partnerships and improved data, signaling a patient,...
Investors are seeing renewed momentum in xanadu quantum technologies stock as talk of government support and industry...
OpenAI wins a Pentagon deal to deploy its AI in classified systems as Anthropic is designated a supply chain risk by ...
A rocket-test explosion at Cape Canaveral spared critical launch-pad components, preserving a path back to flight for...
The February payroll report shows the u.s. economy lost 92,000 jobs, signaling a cooler labor market despite earlier ...
Markets bounce and retreat. This guide explains why here's buying bitcoin right can fit into a balanced, long-term in...
Mega-cap tech names are offering ballast as markets wobble, but the rally is fragile and depends on earnings momentum...
A flood of AI-focused stock offerings could add trillions in market value and test whether buyers can keep up with ne...
Ciena, Lumentum and Coherent led a rally in optical-tech stocks as quarterly results point to sustained AI-driven dem...